On Invalid Date, Accolade (NASDAQ: ACCD) reported Q1 2024 earnings per share (EPS) of -$0.09, up 76.32% year over year. Total Accolade earnings for the quarter were -$7.51 million. In the same quarter last year, Accolade's earnings per share (EPS) was -$0.38.
As of Q2 2024, Accolade's earnings has grown year over year. Accolade's earnings in the past year totalled -$99.81 million.
What was ACCD's revenue last quarter?
On Invalid Date, Accolade (NASDAQ: ACCD) reported Q1 2024 revenue of $124.83 million up 26.06% year over year. In the same quarter last year, Accolade's revenue was $99.03 million.
What was ACCD's revenue growth in the past year?
As of Q2 2024, Accolade's revenue has grown 14.09% year over year. This is 5.05 percentage points higher than the US Health Information Services industry revenue growth rate of 9.04%. Accolade's revenue in the past year totalled $414.29 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.